• Vt. to get $1.1 million drug settlement
    November 17,2012

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In

    RANDOLPH — Police are seeking information following a break-in at an interstate rest stop. Full Story

    MONTPELIER — High deductibles for health plans causing financial hardship for Americans... Full Story

    DANVILLE — From paved city streets to hilly dirt roads, runoff from Vermont’s... Full Story

    More Articles
    • VIDEOS
    • PHOTOS